Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases - Wikidata - wikimedia - TriplyDB

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

http://www.wikidata.org/entity/Q26744232

about

Association between circulating fibroblast growth factor 21 and mortality in end-stage renal disease.Fibroblast growth factor 21: a regulator of metabolic disease and health span.N-3 polyunsaturated fatty acids increase hepatic fibroblast growth factor 21 sensitivity via a PPAR-γ-β-klotho pathway.Fibroblast growth factor 21 inhibition aggravates cardiac dysfunction in diabetic cardiomyopathy by improving lipid accumulation.Thermogenic capacity of human periaortic adipose tissue is transformed by body weight.

P2860

Q33764747-74DC7570-2C23-4A36-9F1E-CDB474D8BB88 Q38755577-92CF0A07-FE27-4398-9CE0-E6629A19FB4D Q38858879-55158F72-97D9-40A1-B7FB-431EF1195330 Q49630025-C02FD431-ED15-46AA-8E2C-C8B208F75243 Q55093363-3517FB6C-9DA1-492D-90C8-4D55A8C91CC3

P2860

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

http://www.wikidata.org/entity/Q26744232

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@ast

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@en

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@nl

type

label

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@ast

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@en

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@nl

prefLabel

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@ast

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@en

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@nl

P1433

Q26744232-28DB35FD-1EA1-4D72-945E-4234A89A76F8

P1476

Q26744232-3DA1029A-877E-49F5-9298-9D4FD01B4562

P2093

Q26744232-085B7365-ECD8-492D-8D8E-3F4013788A2B

Q26744232-08B97387-2B78-49AD-8FE3-C2489C7C7334

Q26744232-11B87D36-18F9-41E4-BEEA-A4112AFC8162

Q26744232-4B11044D-D203-4009-A549-AB21201186F7

Q26744232-73D09898-E34D-45B6-92FD-57385946A7EC

Q26744232-B411FB6F-4FB1-4EE2-9736-6551A3C77338

Q26744232-BD38D055-A6D8-40B7-A0E8-13F456D3AF18

Q26744232-D31A5484-5D30-49B2-B4F3-6424B032FED8

Q26744232-D9DF1BB4-F736-491C-9D17-798F576953C9

Q26744232-E82FFB8B-F1EE-40E4-A10B-025C9FD880D2

P275

Q26744232-672B9594-C362-49C9-BC9F-38016FEC4F9E

P2860

Q26744232-020A2ED4-2E4A-45C7-9A30-DB6B23D2E0C4

Q26744232-0A5B8FAC-4ED3-40BA-8EDB-46017614D033

Q26744232-0AD1D746-B7E1-46CA-AF8D-24C1C3A2C14D

Q26744232-0DD5B2B5-10AF-4ED4-A7B2-6F6A6BB42F18

Q26744232-0E790CDE-4668-450E-975F-6FDCCAEF3502

Q26744232-0EC984D3-ECAD-4201-B178-BE98132B798D

Q26744232-102880AC-3C0C-4935-AD8E-D413A671754E

Q26744232-18B04167-4949-4942-AC28-AADDE5F87BAF

Q26744232-1F80A881-88BB-4E18-80D0-950AC5F990E9

Q26744232-2482C690-E0DF-45D0-B76D-E2F6EB3DDB5A

P304

Q26744232-76A8EF69-EA2E-4864-A381-6F86C95F5D79

P31

Q26744232-B48EF7CB-ABF4-4FFD-B3FB-D399316EA4CD

Q26744232-E35FB7BA-0E4B-426A-99F7-575D83F022A8

P3181

Q26744232-0CD463B1-CEF6-4B14-91F2-734CD9756B5F

P356

Q26744232-47F56DEC-41FD-4F47-8DA4-477713B4B7E6

P407

Q26744232-8F9A0269-FD56-4534-AA5D-FF06BB513BF0

P478

Q26744232-8484BBA8-D102-4367-A5DC-789F6D0C8A2F

P5008

Q26744232-24642937-A386-4847-8C9B-8B7DD8ADCAC2

P577

Q26744232-899F3DCB-3F85-4296-973C-6538A3B72C7D

P5875

Q26744232-5B9C312F-DF60-4777-AD77-60B86D02F0C7

P698

Q26744232-61B8942C-5148-4B3E-8E38-B4F3273E3A48

P921

Q26744232-3ADB1420-B5F1-4028-9D87-E1F522104AF4

Q26744232-7CBD93D8-B6B4-4275-A1A7-CC51926ABE4E

Q26744232-BEA100DF-258F-4590-9DF8-A90E5B3BB910

P932

Q26744232-B24B22B2-A8D4-4B3B-BD3E-1F2BC1A6033D

P3181

P356

P1433

Journal of Diabetes Research

P1476

Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases

@en

P2093

Chi Zhang

http://www.w3.org/2001/XMLSchema#string

Fangfang Zhang

http://www.w3.org/2001/XMLSchema#string

Lechu Yu

http://www.w3.org/2001/XMLSchema#string

Luqing He

http://www.w3.org/2001/XMLSchema#string

Peng Cheng

http://www.w3.org/2001/XMLSchema#string

Xiaokun Li

http://www.w3.org/2001/XMLSchema#string

Xiaoqing Yan

http://www.w3.org/2001/XMLSchema#string

Xiufei Lin

http://www.w3.org/2001/XMLSchema#string

Xuemian Lu

http://www.w3.org/2001/XMLSchema#string

Yi Tan

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Identification of a novel FGF, FGF-21, preferentially expressed in the liver

betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

FGF-21 as a novel metabolic regulator.

Atherosclerosis

Fibroblast growth factor 21: from pharmacology to physiology

Recent developments in the cell biology of basic fibroblast growth factor

Inventing new medicines: The FGF21 story

Pathophysiological roles of FGF signaling in the heart

P304

1540267

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1768649

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/1540267

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-05-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

302633645

http://www.w3.org/2001/XMLSchema#string

P698

27247947

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4876232

http://www.w3.org/2001/XMLSchema#string